全文获取类型
收费全文 | 201748篇 |
免费 | 4483篇 |
国内免费 | 505篇 |
专业分类
耳鼻咽喉 | 2817篇 |
儿科学 | 7678篇 |
妇产科学 | 5945篇 |
基础医学 | 25947篇 |
口腔科学 | 6155篇 |
临床医学 | 15798篇 |
内科学 | 36744篇 |
皮肤病学 | 4702篇 |
神经病学 | 12165篇 |
特种医学 | 11004篇 |
外国民族医学 | 97篇 |
外科学 | 30444篇 |
综合类 | 1090篇 |
一般理论 | 2篇 |
预防医学 | 16619篇 |
眼科学 | 4353篇 |
药学 | 13804篇 |
2篇 | |
中国医学 | 143篇 |
肿瘤学 | 11227篇 |
出版年
2021年 | 430篇 |
2018年 | 3835篇 |
2017年 | 4080篇 |
2016年 | 3373篇 |
2015年 | 5080篇 |
2014年 | 4576篇 |
2013年 | 3711篇 |
2012年 | 10283篇 |
2011年 | 5232篇 |
2010年 | 2488篇 |
2009年 | 4133篇 |
2008年 | 2503篇 |
2007年 | 3199篇 |
2006年 | 3438篇 |
2005年 | 11542篇 |
2004年 | 12981篇 |
2003年 | 8531篇 |
2002年 | 3687篇 |
2001年 | 4469篇 |
2000年 | 1800篇 |
1999年 | 5924篇 |
1998年 | 555篇 |
1992年 | 6908篇 |
1991年 | 7143篇 |
1990年 | 7384篇 |
1989年 | 6984篇 |
1988年 | 6501篇 |
1987年 | 6265篇 |
1986年 | 5982篇 |
1985年 | 5266篇 |
1984年 | 3608篇 |
1983年 | 2934篇 |
1982年 | 1018篇 |
1981年 | 777篇 |
1980年 | 846篇 |
1979年 | 3843篇 |
1978年 | 2372篇 |
1977年 | 1798篇 |
1976年 | 1564篇 |
1975年 | 2487篇 |
1974年 | 3117篇 |
1973年 | 2753篇 |
1972年 | 2765篇 |
1971年 | 2749篇 |
1970年 | 2562篇 |
1969年 | 2471篇 |
1968年 | 2250篇 |
1967年 | 2169篇 |
1966年 | 1902篇 |
1965年 | 1133篇 |
排序方式: 共有10000条查询结果,搜索用时 31 毫秒
1.
Nicla La Verde Agostino Riva Maria Silvia Cona Arianna Gabrieli Monica Cattaneo Cinzia Fasola Giuseppe Lipari Claudia De Stradis Valentina Favorito Benedetta Lombardi Stocchetti Davide Chizzoniti Alice Covizzi Eliana Rulli Francesca Galli Lorenzo Ruggieri Anna Gambaro Sabrina Ferrario Davide Dalu Maciej S. Tarkowski 《International journal of cancer. Journal international du cancer》2023,152(4):661-671
Previous studies on the immunogenicity of SARS-CoV-2 mRNA vaccines showed a reduced seroconversion in cancer patients. The aim of our study is to evaluate the immunogenicity of two doses of mRNA vaccines in solid cancer patients with or without a previous exposure to the virus. This is a single-institution, prospective, nonrandomized study. Patients in active treatment and a control cohort of healthy people received two doses of BNT162b2 (Comirnaty, BioNTech/Pfizer, The United States) or mRNA-1273 (Spikevax, Moderna). Vaccine was administered before starting anticancer therapy or on the first day of the treatment cycle. SARS-CoV-2 antibody levels against S1, RBD (to evaluate vaccine response) and N proteins (to evaluate previous infection) were measured in plasma before the first dose and 30 days after the second one. From January to June 2021, 195 consecutive cancer patients and 20 healthy controls were enrolled. Thirty-one cancer patients had a previous exposure to SARS-CoV-2. Cancer patients previously exposed to the virus had significantly higher median levels of anti-S1 and anti-RBD IgG, compared to healthy controls (P = .0349) and to cancer patients without a previous infection (P < .001). Vaccine type (anti-S1: P < .0001; anti-RBD: P = .0045), comorbidities (anti-S1: P = .0274; anti-RBD: P = .0048) and the use of G-CSF (anti-S1: P = .0151) negatively affected the antibody response. Conversely, previous exposure to SARS-CoV-2 significantly enhanced the response to vaccination (anti-S1: P < .0001; anti-RBD: P = .0026). Vaccine immunogenicity in cancer patients with a previous exposure to SARS-CoV-2 seems comparable to that of healthy subjects. On the other hand, clinical variables of immune frailty negatively affect humoral immune response to vaccination. 相似文献
2.
Buket Bakan Fatih Oltulu Yeliz Y?ld?r?m Altu? Yava?o?lu Sinan Akg?l Nefise ülkü Karabay Yava?o?lu 《Arhiv za higijenu rada i toksikologiju》2023,74(3):207
The aim of this safety study in mice was to determine in vivo toxicity and biodistribution potential of a single and multiple doses of L-glutamic acid-g-p(HEMA) polymeric nanoparticles as a drug delivery system. The single dose did not cause any lethal effect, and its acute oral LD50 was >2.000 mg/kg body weight (bw). Multiple doses (25, 50, or 100 mg/kg bw) given over 28 days resulted in no significant differences in body and relative organ weights compared to control. These results are supported by biochemical and histological findings. Moreover, nanoparticle exposure did not result in statistically significant differences in micronucleus counts in bone marrow cells compared to control. Nanoparticle distribution was time-dependent, and they reached the organs and even bone marrow by hour 6, as established by ex vivo imaging with the IVIS® spectrum imaging system. In conclusion, L-glutamic acid-g-p(HEMA) polymeric nanoparticles appear biocompatible and have a potential use as a drug delivery system.KEY WORDS: biocompatibility, blood biochemistry, genotoxicity, histology, in vivo toxicity, micronucleus test, polymers 相似文献
4.
5.
6.
7.
8.
Andrea Garatti Andrea Daprati Marzia Cottini Claudio F. Russo Margherita Dalla Tomba Giovanni Troise Antonio Salsano Francesco Santini Roberto Scrofani Francesca Nicolò Elisa Mikus Alberto Albertini Luca Di Marco Davide Pacini Marco Picichè Loris Salvador Guglielmo M. Actis Dato Paolo Centofanti Lorenzo Menicanti 《The Annals of thoracic surgery》2021,111(4):1242-1251
9.
10.
Lorenzo Alibardi 《Developmental dynamics》2022,251(9):1404-1413
An evolutionary hypothesis explaining failure of regeneration among vertebrates is presented. Regeneration derives from postembryonic processes present during the life cycles of fish and amphibians that include larval and metamorphic phases with broad organ reorganizations. Developmental programs imprinted in their genomes are re-utilized with variations also in adults for regeneration. When vertebrates colonized land adopting the amniotic egg, some genes driving larval changes, and metamorphosis were lost and new genes evolved, further limiting regeneration. These included neural inhibitors for maintaining complex nervous systems, behavior and various levels of intelligence, and adaptive immune cells. The latter, that in anamniotes are executioners of metamorphic reorganization, became intolerant to embryonic-oncofetal-antigens impeding organ regeneration, a process that requires de-differentiation of adult cells and/or expansion of stem cells where these early antigens are formed. The evolution of terrestrial lifecycles produced vertebrates with complex bodies but no longer capable to regenerate their organs, mainly repaired by regengrow. Efforts of regenerative medicine to improve healing in humans should determine the diverse developmental pathways evolved between anamniotes and amniotes before attempting genetic manipulations such as the introduction of “anamniote regenerative genes” in amniotes. This operation may determine alteration in amniote developmental programs leading to teratomes, cancer, or death. 相似文献